Skip to main content Skip to navigation

Health-related ECR Workshop: Careers & Opportunities

Friday 12 May 2023, 09.30am - 2.00pm

Location: IBRB Lecture Theatre, Gibbet Hill, University of Warwick

About the event:

The Health Global Research Priority is holding a one-day event that will bring together Early Career Researchers involved in health-related research from across departments and faculties/disciplines at the University. This event will include the following:

  • 3 minute ECR health-related project presentations (First prize worth £175, second prize worth £75)
  • ECR health-related poster sessions (First prize worth £175, second prize worth £75) feel free to recycle posters you already have
  • Presentations and discussion forums ECR career development and opportunities
  • Keynote talks from external speakers from industry and healthcare on career path experiences and opportunities
  • Networking for ECRs across departments and faculties


(This may be subject to change) - please register to attend - limited places available





Registration and refreshments

Posters can be set up in the Foyer



Lecture Theatre


Welcome and introduction

Lawrence Young and Michael Chappell will give an overview of the day



Lecture Theatre


Antiviral drug discovery a journey from academia to industry- there and back again

Eddy Littler has been a virologist for around 40 years, first in academia, then joining Wellcome Research Laboratories in the UK, and eventually becoming responsible for about half of the antiviral research programmes. He then entered GSK during the M&A as Head of Antiviral Research. His next move was to Sweden, where he worked for the pharmaceutical company Medivir as Senior Director of Lead Discovery and Head of the UK site. He led the team that discovered the Hepatitis C drug simeprevir (Olysio), later marketed by J&J. Then, after a journey into the CRO space, Eddy joined ReViral Ltd, initially as CEO working on RSV. ReViral was sold in 2022 to Pfizer for $525m. Eddy is a founder of a not-for-profit company called Collaborative Community against Coronavirus (3C), which has grants from the Bill and Melinda Gates Foundation and Novo Nordisk to identify drugs suitable for pandemic preparedness against future coronaviruses and Nipah virus. Eddy is also the Executive Chairman of Domainex Ltd. He 'retired' in 2022 to the Lake District.



Lecture Theatre


Infectious Disease Modelling in Global Partnerships

Professor Lisa J. White, from the University of Oxford, is a mathematical modeller with a focus on health and policymaking. In addition to academia, Lisa works in the commercial and education sectors. Her work combines within- and between- host infection models with multi-strain/species modelling to explore antimicrobial resistance and integrated public health strategy. Lisa’s modelling work is participatory, with models for malaria and other diseases being developed in close collaboration with national control programs, international decision-makers, funders and donors. Inspired by her experiences of living and working in Africa and Asia, Lisa is actively engaged in equitable global health research and capacity development.



Lecture Theatre


3-minute ECR health-related project presentations

Listen to the presentations





ECR health-related poster sessions and refreshments

A chance to look at the submitted posters



Lecture Theatre


Careers Team

Presentation and questions with the Warwick Careers Team

"Careers in the Healthcare Sector"



Lecture Theatre   Mathematical Modelling in Pharmaceutical Research James Yates will talk about his career path that now includes 18 years in drug discovery. He first trained as a mathematician, gaining an MMath degree at the University of Warwick before moving to the School of Engineering for his PhD studies. His PhD project was more medically aligned, investigating the use of electronic noses to analyse medical samples. He the obtained a post doctoral position with AstraZeneca and moved up to the North West of England for this – subsequently working there and in Cambridge with AZ for 16 years. He has more recently moved to GSK and runs the Pharmacokinetic- Pharmacodynamic modelling team supporting GSK’s research portfolio. James will talk about the importance on interdisciplinary work in pharmaceutical research.





Lunch / Networking / Career stands

A buffet lunch will be provided, a chance to network and talk to our career advisors who will be set up in the Foyer



Lecture Theatre



Winners will be revealed



Lecture Theatre


Closing remarks


Register here

If you have any queries about the event, please contact r dot philippou at warwick dot ac dot uk